Accessibility and language tool guide
Skip to content
Leeds Community Healthcare NHS Trust Logo
Careers Contact Us
  • Home
  • Our services (A to Z)
  • About us
    • Access to information
    • Equality and diversity
    • Research
    • Awards
    • Infection prevention and control
    • Clinical and medical education and training
    • Board of directors
    • Working in partnership
    • Safeguarding children and adults
    • Charity
    • Sustainability
  • News
  • Join our team
    • Why work for us?
    • Flexible staff
    • Newly qualified graduates
    • Vacancies
    • Apprenticeships
    • Working and living in Leeds
  • Patient experience and engagement
    • Compliments, comments and complaints
    • Your feedback and experience
    • Person-centred care
    • Get involved
    • Thinking about using a camera or other equipment to monitor someone’s care?
    • Help to access and attend your appointment
    • About Me project
  • Contact us
    • Plan your journey
    • Location finder
    • Press and media enquiries
Skip to content
Leeds Community Healthcare NHS Trust Logo
  • Home
  • Our services (A to Z)
  • About us
    • Access to information
    • Equality and diversity
    • Research
    • Awards
    • Infection prevention and control
    • Clinical and medical education and training
    • Board of directors
    • Working in partnership
    • Safeguarding children and adults
    • Charity
    • Sustainability
  • News
  • Join our team
    • Why work for us?
    • Flexible staff
    • Newly qualified graduates
    • Vacancies
    • Apprenticeships
    • Working and living in Leeds
  • Patient experience and engagement
    • Compliments, comments and complaints
    • Your feedback and experience
    • Person-centred care
    • Get involved
    • Thinking about using a camera or other equipment to monitor someone’s care?
    • Help to access and attend your appointment
    • About Me project
  • Contact us
    • Plan your journey
    • Location finder
    • Press and media enquiries
Leeds Community Healthcare NHS Trust Logo
/Our services (A to Z)/Diabetes/Type 2 diabetes/Treating your diabetes/Medication for type 2 diabetes

Medication for type 2 diabetes

There are several groups of diabetes medicines that work in different ways to help lower your blood glucose levels. Your healthcare team will review the medication you are taking, your other health conditions, and your blood glucose levels and discuss suitable options with you so a shared decisions about treatment can be made. It may be that you need up to 4 different medications over time to control your blood glucose.

Type 2 diabetes treatments to lower blood glucose are guided by national guidelines. Treatment often starts with oral metformin and a medicine called oral sodium glucose co transporter 2 inhibitors, or SGLT-2 inhibitor (for example, dapagliflozin, empagliflozin, or other ‘gliflozins’). Taking both of these together early on, can help control your diabetes quickly and protect your organs such as your heart and kidney from the effects of high glucose levels.

If these medicines are not suitable for you, or your blood glucose levels remain high, you may need other medicines.

The information below gives an overview of the different groups of medicines available that can lower blood glucose; how they work, the medicines available in each group, their commonly recognised side effects and some other helpful information. The patient information leaflet that is found in your box of medication lists all the information you need to know.

Testing your blood glucose levels

Depending on the medicine used to lower your blood glucose, you may need to test your glucose levels at home. Your healthcare team will advise on this, see separate information on top 10 blood glucose tips

Advice for when you are ill

See type 2 diabetes (what to do when you are ill)

Oral options

Medicine group

Biguanides: Metformin

This is the only medicine available in this group.

How this medicine   works Metformin lowers blood glucose by lowering the amount of glucose the liver releases and makes your body more sensitive to insulin.

It doesn’t cause weight gain and it has a low risk of causing low blood glucose levels (hypoglycaemia), as long as you are not taking it with a sulphonylurea, repaglinide or insulin.

Licensed preparations and how to take your medication Metformin is commonly given  as:

  • Modified release tablets
  • Normal release tablets

Your healthcare professional will advise on the dose to take.

Metformin should be taken with meals and the dose increased slowly to reduce stomach side effects. It is normally taken once, or up to three times a day.

Common side effects Stomach side effects such as feeling or being sick, diarrhoea, stomach-ache and a lack of appetite

Taste disturbances: You should inform a healthcare professional if these symptoms continue or are causing you a problem

Further information Can be found in the manufacturer’s patient information leaflet and in the  Diabetes UK: Metformin uses, how it works and side effects leaflet

Sodium glucose co transporter 2 inhibitors (SGLT2 inhibitors) or gliflozins: Dapagliflozin, Empagliflozin, Canagliflozin, Ertugliflozin

How these medicines   work SGLT-2 inhibitors  remove some of the extra glucose in the urine, which helps to lower blood glucose levels.  They can cause some weight loss and have a low risk of causing low blood glucose levels (hypoglycaemia) as long as you are not taking them with a sulphonylurea, repaglinide or insulin.

They can also help protect kidneys, and support heart health, and are  also be used in the treatment of heart failure and kidney disease

Licensed preparations and how to take your medication There are a few different SGLT2 inhibitors available but in Leeds dapagliflozin tablets (first choice option) and empagliflozin tablets are the most commonly used. Other available SGLT2 inhibitors include canagliflozin and ertugliflozin.

Your healthcare professional will advise on the dose to take.

Tablets should be swallowed whole with a glass of water with or without food once daily.

Leeds SGLT inhibitor leaflet contains further information on this group of medicines, including the more commonly recognised side effects and what to do when ill.

Common side effects See Leeds SGLT inhibitor leaflet

  • Fungal genital infections (for example, thrush around the penis or vagina)
  • Dehydration and dizziness
  • Low blood glucose levels (hypoglycaemia) in combination with some other diabetes medication (for example, insulin or sulphonylurea drugs (gliclazide, glimepiride, glipizide, repaglinide)
Further information Can be found in the manufacturer’s patient information leaflet and in the Diabetes UK: SGLT2 inhibitors patient information leaflet

DPP-4 inhibitors (Gliptins): Sitagliptin, Linagliptin, Alogliptin, Saxagliptin

How these medicines   work Gliptin medications  help the body produce more insulin after eating and lower the amount of glucose produced by the liver when it’s not needed.

They do not usually cause weight gain and have a low risk of causing low blood glucose levels (hypoglycaemia), as long as you are not taking them with a sulphonylurea, repaglinide or insulin.

Licensed preparations and how to take your  medication There are a few different DPP-4 inhibitors (gliptins) available. In Leeds sitagliptin (first choice option) and linagliptin tablets are the most commonly used. Others available include alogliptin and saxagliptin.

Your healthcare professional will advise on the dose to take.

Tablets should be taken with fluid, with or without food once a day.

Common side effects Headache and stomach side effects such feeling or being sick, stomach-ache, or constipation. These usually go away quite quickly. You should inform a healthcare professional if these symptoms continue or are causing you a problem
Uncommon and rarer side effects Inflamed pancreas (insulin producing gland), referred to as pancreatitis has been reported. It is not clear how common this is, but is considered a rare side effect symptoms of pancreatitis include a severe and persistent stomach pain, and feeling of or being sick. It is important to seek medical advice if they occur. If pancreatitis is confirmed treatment with the gliptin should be stopped
Further information Can be found in the manufacturer’s patient information leaflet and in the  Diabetes UK: DPP-4 inhibitors (gliptins) patient information leaflet

Thiazolidinediones (glitazones)

Pioglitazone is the only medicine available in this group

How this medicine   works Pioglitazone helps cells in your body respond better to the insulin your pancreas makes. This can help lower your blood glucose levels.  It may take a few weeks to start working. It has a low risk of causing low blood glucose levels (hypoglycaemia), as long as you are not taking it with a sulphonylurea, repaglinide or insulin.

It is not suitable if you have heart failure, liver disease (unless recommended by a liver specialist), a previous bone fracture (break) caused by osteoporosis, or a history of bladder cancer

Your healthcare team will want to do a blood test to keep a check on how your liver is working whilst on treatment.

Licensed preparation and administration Pioglitazone is available in tablet form.

Your healthcare professional will advise on the dose to take.

Tablets should be taken with fluid, with or without food once a day.

Common side effects
  • Headache, dizziness. You should inform a healthcare professional if these symptoms continue or are causing you a problem
  • Weight gain may occur
  • Fluid retention can occur. If weight gain happens because you are collecting fluid, for example round your ankles, and you get short of breath seek medical advice
  • Bladder cancer has been uncommonly reported on treatment. Seek medical advice if you develop: blood in urine, pain, burning or discomfort when passing urine or an urge to suddenly pass urine  while taking pioglitazone
  • Eye symptoms such as worsening vision or visual disturbances have been reported. Seek medical advice if this occurs
  • An increased risk of bone fractures. Your risk factors for developing a fracture will be assessed before considering pioglitazone
Further information Can be found in the manufacturer’s patient information leaflet and in the  Diabetes UK: Pioglitazone uses, how it works and side effects patient information leaflet

Sulphonylureas

Sulphonylureas: Gliclazide, Glimepiride, Glipizide, Tolbutamide

How this medicines works Sulfonylureas work by making your pancreas (a gland which makes insulin) produce more insulin.

If too much insulin is produced than your body needs these medicines can cause low blood glucose (hypoglycaemia), so it’s important to get the dose right for you. When taking these medicines it is recommended to monitor your blood glucose levels, and you will be provided with a meter and testing equipment. Either yourself or your carer will be given information on how to test your blood glucose levels and how often, as well as how to lower your risk of hypoglycaemia

Licensed preparations and administration There are a few different sulphonylureas available, but in Leeds normal release gliclazide and glimepiride tablets are the most commonly used Others available include glimepiride and tolbutamide.

Your healthcare professional will advise on the dose and frequency to take these

Gliclazide may be needed once or twice a day, while glimepiride is taken once daily. They should be taken with fluid and food.

Common side effects Low blood glucose (Hypoglycaemia). Weight gain may occur (around 2kg is common)

Stomach side effects such as stomach-ache, indigestion, feeling or being sick, diarrhoea, and constipation have rarely been reported. These may be lessened if taken with food. You should inform a healthcare professional if these symptoms continue or are causing you a problem

Further information Can be found in the manufacturers patient information leaflet and in the  Diabetes UK: Sulphonylureas uses, how it works and side effects patient information leaflet.

See also the

  • top 10 blood glucose tips webpage
  • Hypoglycaemia and it’s management

Driving when taking these medications, see the Safe Driving and the DVLA patient information leaflet on the Trend Diabetes website

You shouldn’t drive when taking sulfonylureas if you are not monitoring their blood glucose.

  • Type 2 diabetes: What to do when you are ill

 

 

Contact us

  • Email:lchdiabetes.service@nhs.net
  • Phone: 0113 843 4200 (option 2 for diabetes)
  • Opening hours: Monday to Friday 8:30am to 4:30pm

Locations

  • Armley Moor Health Centre
  • Hunslet Heath Centre
  • Chapeltown Health Centre
  • East Leeds Health Centre

Useful links

  • Diabetes UK: Type 2 diabetes medicine
  • Diabetes UK : GLP-1 agonists

Contact us

  • Email:lchdiabetes.service@nhs.net
  • Phone: 0113 843 4200 (option 2 for diabetes)
  • Opening hours: Monday to Friday 8:30am to 4:30pm

Locations

  • Armley Moor Health Centre
  • Hunslet Heath Centre
  • Chapeltown Health Centre
  • East Leeds Health Centre

Useful links

  • Diabetes UK: Type 2 diabetes medicine
  • Diabetes UK : GLP-1 agonists
survey icon
Tell us what you think

We would love to know what you think of our website and if there is anything we can improve.

Complete our survey and share your thoughts.

Leeds Community Healthcare NHS Trust Logo
Headquarters
Leeds Community Healthcare NHS Trust
White Rose Office Park, Building 3
Millshaw Park Lane
Leeds, LS11 0DL
Useful Links
  • News
  • Current vacancies
  • Contact us
  • Give feedback
Need to speak to someone urgently?
MindMate Website Logo MindWell Leeds Website Logo NHS 111 Logo
© 2026 Leeds Community Healthcare NHS Trust - Website by 6B
  • Accessibility statement
  • Privacy notice
  • Cookie policy
  • Terms and conditions
  • Policies and guidelines